Neumora Therapeutics, Inc. (NMRA)

NASDAQ: NMRA · IEX Real-Time Price · USD

9.19

-0.58 (-5.94%)

At close: May 10, 2024, 4:00 PM

9.18

-0.01 (-0.11%)

After-hours: May 10, 2024, 7:35 PM EDT

Neumora Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	45.48	31.12	24.55
Research & Development	142.72	91.75	55.78
Other Operating Expenses	63.9	13	157
Operating Expenses	252.1	135.87	237.32
Operating Income	-252.1	-135.87	-237.32
Other Expense / Income	-16.44	-4.97	-0.01
Pretax Income	-235.66	-130.9	-237.31
Income Tax	0.27	0	0
Net Income	-235.93	-130.9	-237.31
Shares Outstanding (Basic)	65	27	172
Shares Outstanding (Diluted)	65	27	172
Shares Change	138.99%	-84.16%	-
EPS (Basic)	-3.63	-4.81	-1.38
EPS (Diluted)	-3.63	-4.81	-1.38
Free Cash Flow	-163.4	-115.41	-76.24
Free Cash Flow Per Share	-2.51	-4.24	-0.44
EBITDA	-231.63	-128.21	-235.76
Depreciation & Amortization	4.02	2.7	1.55
EBIT	-235.66	-130.9	-237.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).